• LAST PRICE
    0.6823
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.6846/ 1
  • Ask / Lots
    0.7200/ 1
  • Open / Previous Close
    0.7050 / 0.6823
  • Day Range
    Low 0.6800
    High 0.7195
  • 52 Week Range
    Low 0.4677
    High 4.0000
  • Volume
    27,614
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 0.692
TimeVolumeCOSM
09:45 ET3200.705001
09:50 ET1000.692
09:54 ET2900.6919
09:59 ET3000.6919
10:06 ET1700.691935
10:08 ET4960.6919
10:12 ET97950.692
10:28 ET1000.695
11:02 ET46980.6925
11:11 ET1150.690899
11:15 ET5000.6916
11:22 ET1000.6918
11:26 ET1600.6909
11:29 ET1000.69
11:38 ET1000.6899
12:02 ET1000.6849
12:16 ET1000.6898
12:32 ET1000.6801
12:36 ET18460.68
12:38 ET1110.6801
01:12 ET1400.6801
01:14 ET1000.7141
02:09 ET1740.6856
02:58 ET3970.68
03:50 ET3000.7195
03:57 ET16000.698
03:59 ET23430.6823
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCOSM
Cosmos Health Inc
11.6M
-0.1x
---
United StatesRXMD
Progressive Care Inc
12.9M
-0.6x
---
United StatesMJNA
Medical Marijuana Inc
9.8M
0.0x
---
United StatesSSY
SunLink Health Systems Inc
4.2M
-1.4x
---
United StatesHEWA
HealthWarehouse.com Inc
7.1M
-3.5x
---
United StatesZEOX
ZEO ScientifiX Inc
6.7M
-1.3x
---
As of 2024-05-21

Company Information

Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals and Para pharmaceuticals, including branded generics and over the counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It is also engaged in the research and development (R&D) of patented nutraceuticals and specialized root extracts as well as in the R&D of complex generics and OTC products. It offers Cloudscreen, a multimodal platform specialized in drug repurposing, a process of uncovering new target proteins. It is also specialized in the storage and distribution of pharmaceutical and Para pharmaceutical goods.

Contact Information

Headquarters
141 W. JACKSON BLVD, SUITE 4236CHICAGO, IL, United States 60604
Phone
312-536-3102
Fax
---

Executives

Chairman of the Board, Chief Executive Officer
Grigorios Siokas
Chief Financial Officer
Georgios Terzis
Chief Operating Officer
Nikos Bardakis
Independent Director
Anastasios Aslidis
Independent Director
Suhel Bhutawala

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$11.6M
Revenue (TTM)
$49.6M
Shares Outstanding
16.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
3.00
EPS
$-7.92
Book Value
$3.74
P/E Ratio
-0.1x
Price/Sales (TTM)
0.2
Price/Cash Flow (TTM)
---
Operating Margin
-24.54%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.